HCAT logo

HEALTH CATALYST INC

HCATNASDAQ
πŸ† #3947 by market capUS Equity
$1.75β–Ό $0.02 (βˆ’1.13%)
Market closed Β· at close
πŸ””
Track HCAT
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 1.1%
7dβ–² 0.6%
14dβ–² 0.9%
30dβ–² 6.1%
ytdβ–Ό 26.8%
1yβ–Ό 38.8%
🏦Market Cap
$129M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-7.5%
Declining
πŸ“ŠGross Margin
51.2%
Healthy
πŸ’΅FCF Margin
5.9%
Moderate
βš–οΈP/S Ratio
0.4x
Cheap
Otter Score
68
Fair

Trading Snapshot

Day Range
$1.73 – $1.78
52-Week Range
$0.96 – $3.62
Volume
$1.82B
Avg Volume
$1.32B
Shares Outstanding
73.9M
Next Earnings
Dec 1, 2026

Fundamentals Snapshot

Annual Revenue
$311M
Last Q Revenue
$70M
P/E Ratio
β€”
P/S Ratio
0.4x
EPS (TTM)
$-3.68
Dividend Yield
β€”
Dilution (1yr)
+13.8%

Why Investors Own HCAT

  • βœ“High-growth profile β€” revenue up +14.3% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 53% gross margin and 22% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

HCAT logo

HEALTH CATALYST INC

HCAT
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$311Mβ–² +1.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
33.5%β–Ό βˆ’27.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$36Mβ–Ό βˆ’48.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$237Kβ–Ό βˆ’87.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
71.0Mβ–² +13.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$120Mβ–² +$32M YoY
StockOtter Β· stockotter.space

About HEALTH CATALYST INC

Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
68/100

Analyst Price Target

β“˜
Average Target
$2.24
β–² +28.0% Upside
High Target$2.54
Low Target$1.75
Based on 21 analysts

Latest News & Updates